September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
August 18th 2024
To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.
August 17th 2024
Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.
June 24th 2024
The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.
April 1st 2024
The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.
Going Beyond Dispensing: The Future of Pharmacist Roles
Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.
New Study Examines Why Some Fare Better with the Flu Than Others
A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.
How To Turn Into A ‘Diabetes Pharmacy’
Creating a place where patients seek diabetes care and counseling.
Study Finds Habitual Fish Oil Use Linked to Cardiovascular Benefits
Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.
Drug Shortages Act Needed As Coronavirus Threats Grow
COVID-19 Officially Declared a Pandemic by WHO
The World Health Organization declared the novel coronavirus outbreak a pandemic.
EHR Data Analysis Suggests Need for Improvement in Blood Pressure Management
A new study found several shortcomings in blood pressure management.
CROI 2020: New Data Comparing Descovy, Truvada for HIV PrEP
At the 2020 Conference on Retroviruses and Opportunistic Infections (CROI), longer-term study results on emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for HIV PrEP were presented.
CVS Pharmacy Acquires Schnucks Pharmacies, 11 Will Close
Eleven Schnuck Markets’ pharmacies will close after CVS Pharmacy’s acquisition of 110 Schnuck’s pharmacies.
President Trump Signs Coronavirus Bill as Pharmacies Show Their Value in Outbreak
President Donald Trump has signed a bill that will provide more than $8.3 billion to fight the coronavirus disease outbreak.
6 Ways to Diversify Your Pharmacy's Revenue Streams
Strategies for seizing revenue opportunities outside of the PBM.
What Pharmacies Are Doing to Mitigate Shortages Due to COVID-19
Plus, ASHP comments on the latest drug shortage.
FDA OKs OTC Ibuprofen, Acetaminophen Combination Product
Advil Dual Action, an ibuprofen and acetaminophen fixed-dose combination, has been approved as an OTC product for pain relief.
Using Budgets to Increase Cash Flow for Your Pharmacy
Boost your financial IQ with these tips on how to manage your budget and increase cash flow.
The Apothecary Shoppe: An Inner-City Success Story
Kevin DeMass, RPh, is the owner and leader of a talented team of professionals that encounters a wide variety of patients, ailments, and medications.
Why Does the Varicella Zoster Virus Reactivate as Shingles?
Vaccination is first line of defense.
Report Shows Newer DAA Therapy Highly Effective for HCV, Recommends Universal Screening
A new systematic review demonstrates efficacy of direct-acting antiviral therapies and supports a recommendation for universal screening of hepatitis C virus.
COVID-19 Update: FDA Confirms First Drug Shortage, Other Supply Shortages Continue
The FDA announced the first drug shortage due to COVID-19, and pharmacies are having challenges keeping face masks and hand sanitizers stocked.
FDA OKs First Generic Version of Daraprim
Pyrimethamine (Daraprim) tablets are used to treat toxoplasmosis.
Re-exposure to Chickenpox Boosts Immunity to Shingles
British study supports exogenous boosting theory.
FDA OKs Fast-Acting Orally Disintegrating Tablet for Acute Migraine Treatment
Rimegepant (Nurtec ODT, Biohaven),a fast-acting orally disintegrating tablet, delivers quick and sustained efficacy for patients with migraine.
Pharmacy Groups Express Concerns About Health Care Megamergers
In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.
Investigational Drug May Reduce Symptoms in Refractory GERD
A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.
CDC: New Diabetes Cases Down Among Adults, But On the Rise in Youth
The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.
Benefits of Hypertension Treatments Largely Similar Across Drug Classes
The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.
Pharmacists Concerned About Shortages in Wake of Coronavirus
Separately, a pharmacy association executive urges Americans to receive the flu vaccine.
Informed Pharmacists Can Reduce Barriers to Naloxone in Rural Communities
Regardless of naloxone availability, rural pharmacies can serve as an educational resource for individuals seeking access to the medication.
Analysis: Apixaban Associated with Lower Risks Than Warfarin
A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.
FDA OKs New Non-Statin, LDL-C Lowering Treatment
Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.
Pharmacist Groups Support Supreme Court PBM Case
Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.